Mark Cuban’s Cost-Plus Pricing Is Breaking Pharma’s Patent Playbook
Mark Cuban’s Cost-Plus Pricing Isn’t Just a Pricing Story—It’s a Patent-Playbook Story
The most important thing to understand about Mark Cuban’s cost-plus pricing push isn’t that it’s “cheaper.” It’s that it’s changing the incentives that have governed…
Mark Cuban’s Cost-Plus Pricing Is Breaking Pharma’s Patent Playbook Read Post »
